Limiar de eficiência em avaliações de tecnologias em saúde

Saad, Ricardo; Lemmer, Teresa; Clark, Otávio.
J. bras. econ. saúde (Impr.) ; 9(Suplemento 1): http://www.jbes.com.br/images/v9ns1/115.pdf, Setembro/2017.
Artigo Português | ECOS, LILACS | ID: biblio-859653

Documentos relacionados

  1. Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations.
  2. Emulating Target Trials With Real-World Data to Inform Health Technology Assessment: Findings and Lessons From an Application to Emergency Surgery.
  3. Beyond clinical and cost-effectiveness: The contribution of qualitative research to health technology assessment.
  4. A systematic review of economic evaluations for <i>RPE65</i>-mediated inherited retinal disease including HTA assessment of broader value.
  5. Economic evaluation of genomic/genetic tests: a review and future directions.
  6. Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature.
  7. Dealing With Uncertainty in Early Health Technology Assessment: An Exploration of Methods for Decision Making Under Deep Uncertainty.
  8. Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges.
  9. Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project.
  10. Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost-effectiveness assessment on health utility for targeted medicines.